Mice With Growth Hormone Halted in Middle Age Live Longer
Key claim: An Aging Cell study reports that stopping growth hormone receptor production in middle-aged mice significantly extends their lifespan.
Abstract
Researchers publishing in Aging Cell have described how stopping growth hormone receptor production in midlife significantly lengthens the lives of mice. […]
Why this matters
Midlife-inducible GHR ablation extending mouse lifespan is the translationally relevant version of the classic congenital GHR/IGF-1 longevity phenotype — it tests whether the pathway can still be pulled after developmental windows close, which is the only version of the story that could plausibly map onto a human intervention. The underlying Aging Cell study is already logged in the GH/IGF-1 and mTOR pages; this news-report surfacing indicates the finding is entering the popular-longevity narrative, where the gap between a mouse GHR knockdown and any human GH-axis therapy (dwarfism trade-offs, cancer-risk balance, no human RCT) should be flagged whenever it is cited.